Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

about

Update on melatonin receptors: IUPHAR Review 20.Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home

P2860

Q38868297-3680FB0E-5671-4B69-A92C-7888F6F5F9B5 Q57677461-FF8CD536-6AA8-41D2-AD66-3329F9468254

P2860

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

Item

http://www.wikidata.org/entity/Q38654045

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

@en

type

Item

label

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

@en

prefLabel

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

@en

P1476

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

@en

P2093

Daniel J van Wamelen

http://www.w3.org/2001/XMLSchema#string

Nasir A Aziz

http://www.w3.org/2001/XMLSchema#string

Raymund Ac Roos

http://www.w3.org/2001/XMLSchema#string

P2860

Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Phototransduction by retinal ganglion cells that set the circadian clock

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

The genetics of mammalian circadian order and disorder: implications for physiology and disease

Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice.

Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.

Increased metabolism in the R6/2 mouse model of Huntington's disease.

Circadian rhythms and sleep in human aging.

P304

549-559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NMT.15.45

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285542591

http://www.w3.org/2001/XMLSchema#string

P698

26621387

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

circadian rhythm

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

about

P2860

P2860

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921